Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT04521699
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT04521699
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04521699. Randomized; no masking; primary purpose treatment. Start 2022-01-13 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
- Acronym
- CalmiGo
- Condition
- Myocardial Infarction
- Intervention (Device)
- CalmioGO Stress management device
- Lead sponsor
- Mayo Clinic
- Collaborator
- CalmiGO
Record details
- Record id
cardio:ct-nct04521699- Content hash
9e5cdeaf8be8007d27472edcc5fe2643e18052239e85013036f1216a5ffee3fe